Innovations and challenges in renal cancer

summary statement from the Third Cambridge Conference

Michael B. Atkins, Ronald M. Bukowski, Bernard J. Escudier, Robert A. Figlin, Gary H. Hudes, William G. Kaelin, W. Marston Linehan, David F. McDermott, James W. Mier, Ivan Pedrosa, Brian I. Rini, Sabina Signoretti, Jeffrey A. Sosman, Bin Tean Teh, Christopher G. Wood, Amado J. Zurita, Laura King

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.

Original languageEnglish (US)
Pages (from-to)2247-2251
Number of pages5
JournalCancer
Volume115
Issue numberSUPPL. 10
DOIs
StatePublished - May 15 2009

Fingerprint

Neoplasm Staging
Kidney Neoplasms
Renal Cell Carcinoma
Molecular Biology
Biomarkers
Research
Therapeutics

Keywords

  • Biomarkers
  • Genetics
  • Immunotherapy
  • Renal cancer
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Atkins, M. B., Bukowski, R. M., Escudier, B. J., Figlin, R. A., Hudes, G. H., Kaelin, W. G., ... King, L. (2009). Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference. Cancer, 115(SUPPL. 10), 2247-2251. https://doi.org/10.1002/cncr.24229

Innovations and challenges in renal cancer : summary statement from the Third Cambridge Conference. / Atkins, Michael B.; Bukowski, Ronald M.; Escudier, Bernard J.; Figlin, Robert A.; Hudes, Gary H.; Kaelin, William G.; Linehan, W. Marston; McDermott, David F.; Mier, James W.; Pedrosa, Ivan; Rini, Brian I.; Signoretti, Sabina; Sosman, Jeffrey A.; Teh, Bin Tean; Wood, Christopher G.; Zurita, Amado J.; King, Laura.

In: Cancer, Vol. 115, No. SUPPL. 10, 15.05.2009, p. 2247-2251.

Research output: Contribution to journalArticle

Atkins, MB, Bukowski, RM, Escudier, BJ, Figlin, RA, Hudes, GH, Kaelin, WG, Linehan, WM, McDermott, DF, Mier, JW, Pedrosa, I, Rini, BI, Signoretti, S, Sosman, JA, Teh, BT, Wood, CG, Zurita, AJ & King, L 2009, 'Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference', Cancer, vol. 115, no. SUPPL. 10, pp. 2247-2251. https://doi.org/10.1002/cncr.24229
Atkins MB, Bukowski RM, Escudier BJ, Figlin RA, Hudes GH, Kaelin WG et al. Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference. Cancer. 2009 May 15;115(SUPPL. 10):2247-2251. https://doi.org/10.1002/cncr.24229
Atkins, Michael B. ; Bukowski, Ronald M. ; Escudier, Bernard J. ; Figlin, Robert A. ; Hudes, Gary H. ; Kaelin, William G. ; Linehan, W. Marston ; McDermott, David F. ; Mier, James W. ; Pedrosa, Ivan ; Rini, Brian I. ; Signoretti, Sabina ; Sosman, Jeffrey A. ; Teh, Bin Tean ; Wood, Christopher G. ; Zurita, Amado J. ; King, Laura. / Innovations and challenges in renal cancer : summary statement from the Third Cambridge Conference. In: Cancer. 2009 ; Vol. 115, No. SUPPL. 10. pp. 2247-2251.
@article{5c6ea503453d457ebca74ba16e14c2f6,
title = "Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference",
abstract = "The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.",
keywords = "Biomarkers, Genetics, Immunotherapy, Renal cancer, Vascular endothelial growth factor",
author = "Atkins, {Michael B.} and Bukowski, {Ronald M.} and Escudier, {Bernard J.} and Figlin, {Robert A.} and Hudes, {Gary H.} and Kaelin, {William G.} and Linehan, {W. Marston} and McDermott, {David F.} and Mier, {James W.} and Ivan Pedrosa and Rini, {Brian I.} and Sabina Signoretti and Sosman, {Jeffrey A.} and Teh, {Bin Tean} and Wood, {Christopher G.} and Zurita, {Amado J.} and Laura King",
year = "2009",
month = "5",
day = "15",
doi = "10.1002/cncr.24229",
language = "English (US)",
volume = "115",
pages = "2247--2251",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "SUPPL. 10",

}

TY - JOUR

T1 - Innovations and challenges in renal cancer

T2 - summary statement from the Third Cambridge Conference

AU - Atkins, Michael B.

AU - Bukowski, Ronald M.

AU - Escudier, Bernard J.

AU - Figlin, Robert A.

AU - Hudes, Gary H.

AU - Kaelin, William G.

AU - Linehan, W. Marston

AU - McDermott, David F.

AU - Mier, James W.

AU - Pedrosa, Ivan

AU - Rini, Brian I.

AU - Signoretti, Sabina

AU - Sosman, Jeffrey A.

AU - Teh, Bin Tean

AU - Wood, Christopher G.

AU - Zurita, Amado J.

AU - King, Laura

PY - 2009/5/15

Y1 - 2009/5/15

N2 - The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.

AB - The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.

KW - Biomarkers

KW - Genetics

KW - Immunotherapy

KW - Renal cancer

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=65949090273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65949090273&partnerID=8YFLogxK

U2 - 10.1002/cncr.24229

DO - 10.1002/cncr.24229

M3 - Article

VL - 115

SP - 2247

EP - 2251

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - SUPPL. 10

ER -